Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.
Adam RJ, Hisert KB, Dodd JD, Grogan B, Launspach JL, Barnes JK, Gallagher CG, Sieren JP, Gross TJ, Fischer AJ, Cavanaugh JE, Hoffman EA, Singh PK, Welsh MJ, McKone EF, Stoltz DA.
Adam RJ, et al. Among authors: sieren jp.
JCI Insight. 2016 Apr 7;1(4):e86183. doi: 10.1172/jci.insight.86183.
JCI Insight. 2016.
PMID: 27158673
Free PMC article.